Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00761_DB01409_nanopub.RA8OKt6sMyUhP4SK2qlQ6rqTZuivfxK-IRsB33Svnvdkc#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00761_DB01409 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00761_DB01409 label "DDI between Potassium Chloride and Tiotropium - The ulcerative effects of solid oral dosage forms of KCl may be enhanced by Tiotropium, an anticholinergic. Anticholinergics slow gastric emptying, increasing the contact time between the gastrointestinal mucosa and KCl. Prolonged exposure to KCl increases the risk of gastric and intestinal irritation and ulceration. Solid oral dosage forms of KCl should be avoided; alternatives include liquid or effervescent potassium preparations. [drugbank_resource:DB00761_DB01409]" assertion.
- drugbank_resource:DB00761_DB01409 identifier "drugbank_resource:DB00761_DB01409" assertion.
- drugbank_resource:DB00761_DB01409 title "DDI between Potassium Chloride and Tiotropium - The ulcerative effects of solid oral dosage forms of KCl may be enhanced by Tiotropium, an anticholinergic. Anticholinergics slow gastric emptying, increasing the contact time between the gastrointestinal mucosa and KCl. Prolonged exposure to KCl increases the risk of gastric and intestinal irritation and ulceration. Solid oral dosage forms of KCl should be avoided; alternatives include liquid or effervescent potassium preparations." assertion.
- drugbank:DB00761 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00761_DB01409 assertion.
- drugbank:DB01409 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00761_DB01409 assertion.